Rigel Pharmaceuticals Inc. Q3 Earnings Summary - Markets Insider

Nov 7, 2024 · (RTTNews) - Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL): Earnings: $12.42 million in Q3 vs. -$5.69 million in the sam...

$12.42
OFF

Rigel Pharmaceuticals Inc. Q3 Earnings Summary - Markets Insider

1 week from now

Nov 7, 2024 · (RTTNews) - Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL): Earnings: $12.42 million in Q3 vs. -$5.69 million in the sam...

businessinsider.com

44%
OFF

Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Call Highlights ...

1 week from now

Nov 8, 2024 · Rigel Pharmaceuticals Inc (NASDAQ:RIGL) reported a 44% increase in net sales for the third quarter of 2024 compared to the same period in 2023, driven by strong …

yahoo.com

8%
OFF

Rigel Pharma Q3 Soars: Revenue Hits $55.3M, REZLIDHIA Sales …

1 week from now

Nov 7, 2024 · Rigel Pharmaceuticals reported strong Q3 2024 financial results with total revenue of $55.3 million, including TAVALISSE net sales of $26.3 million (8% growth), REZLIDHIA net …

stocktitan.net

$0.70
OFF

Rigel Pharmaceuticals (RIGL) Q3 Earnings And Revenues Top …

1 week from now

Nov 7, 2024 · Rigel Pharmaceuticals (RIGL Quick Quote RIGL - Free Report) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.01 per …

zacks.com

$0.70
OFF

Rigel Pharmaceuticals (RIGL) Q3 Earnings And Revenues Top

1 week from now

Nov 7, 2024 · Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.30 per …

nasdaq.com

$20.95
OFF

Rigel Pharmaceuticals Inc. Q3 Earnings Summary - Nasdaq

1 week from now

Nov 2, 2021 · (RTTNews) - Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL): -Earnings: -$20.95 million in Q3 vs. -$14.17 million in the same period last year.

nasdaq.com

75%
OFF

Rigel Pharmaceuticals, Inc. - MarketScreener.com

1 week from now

16 hours ago · Other stock markets. 12:53:37 2025-01-16 pm EST 5-day change 1st Jan Change 17.70 USD-1.75% ... Summary Quotes Charts ... Rigel Pharmaceuticals, Inc., Q3 2024 …

marketscreener.com

$11.49
OFF

EARNINGS SUMMARY: Details Of Rigel Pharmaceuticals Inc. Q3 …

1 week from now

Nov 5, 2019 · (RTTNews) - Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL): -Earnings: -$11.49 million in Q3 vs. -$23.77 million in the ...

businessinsider.com

36%
OFF

Rigel Pharmaceuticals Sets 2025 Sales Outlook Above Estimates

1 week from now

Rigel Pharmaceuticals, Inc. (RIGL) Q3 2024 Earnings Call Transcript Rigel Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation Rigel stock rallies 36% after Q3 earnings beat

msn.com

$57
OFF

Rigel Pharmaceuticals Reports Preliminary Q4 Results; Issues 2025 …

1 week from now

3 days ago · Rigel Pharmaceuticals, Inc. said it expects to report fourth quarter total revenue of $57.6 million, compared to $35.8 million for the same period of 2023. Rigel expects to report …

rttnews.com

$0.08
OFF

EARNINGS SUMMARY: Details Of Rigel Pharmaceuticals Inc. Q3 …

1 week from now

Nov 5, 2020 · -EPS: -$0.08 in Q3 vs. -$0.07 in the same period last year. -Analysts projected -$0.12 per share -Revenue: $1 EARNINGS SUMMARY: Details of Rigel Pharmaceuticals Inc. …

nasdaq.com

$57
OFF

Rigel Pharmaceuticals Reports Preliminary Q4 Results ... - Markets …

1 week from now

3 days ago · (RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) said it expects to report fourth quarter total revenue of $57.6 million, compared to $35.8 million for the same period of 2023. …

businessinsider.com

$38
OFF

NJ Pharmaceutical Exec Used Insider Info To Avoid $38 Million …

1 week from now

Dec 27, 2024 · A 54-year-old former NJ pharmaceutical executive used insider information to avoid $38 million in losses, authorities said. Dale Chappell, who currently lives in Switzerland …

dailyvoice.com

FAQs about Rigel Pharmaceuticals Inc. Q3 Earnings Summary - Markets Insider Coupon?

How did Rigel Pharmaceuticals perform in the third quarter of 2024?

Rigel Pharmaceuticals Inc (NASDAQ:RIGL) reported a 44% increase in net sales for the third quarter of 2024 compared to the same period in 2023, driven by strong performance across its commercial portfolio. ...

What is Rigel Pharmaceuticals' fourth quarter revenue?

(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) said it expects to report fourth quarter total revenue of $57.6 million, compared to $35.8 million for the same period of 2023. Rigel expects to report fourth quarter net product sales of $46.5 million, compared to $29.5 million for the same period of 2023. ...

Is Rigel Pharmaceuticals Inc (Rigl) a good stock to buy?

Rigel Pharmaceuticals Inc (RIGL) reports a 44% increase in net sales and achieves positive net income, driven by robust product performance and international expansion. ...

What is Rigel Pharmaceuticals?

Rigel Pharmaceuticals, Inc. is a biotechnology company that discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. They offer Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. ...

How does the Rigel Pharmaceuticals stock hold a sell signal?

The Rigel Pharmaceuticals stock displays sell signals from both short and long-term moving averages, giving a more negative forecast for the stock. Additionally, there is a general sell signal from the relationship between the two signals where the long-term average is above the short-term average. ...

Does Rigel Pharmaceuticals pay a dividend?

Rigel Pharmaceuticals does not currently pay a dividend. Rigel Pharmaceuticals does not have a long track record of dividend growth. Rigel Pharmaceuticals has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). ...